AstraZeneca To Leverage Global Industrial-Scale Manufacturing, Digital Capabilities To Boost U.S. Renewable Natural Gas Productivity
AstraZeneca is leveraging its global industrial-scale manufacturing and digital capabilities to boost US renewable natural gas (RNG) productivity through a planned expanded collaboration with Vanguard Renewables. With an ambition of achieving a multiple fold increase in productivity, the collaboration aims to accelerate parity with fossil fuel-generated natural gas.
Drawing on AstraZeneca’s global manufacturing, supply chain, digital and scientific expertise, the companies plan to work together to increase RNG yield and generate a step change improvement in the production of RNG. Technological improvements and enhanced production can increase access and cost-effectiveness of RNG, a current barrier to widespread renewable energy deployment. The collaboration also aims to add RNG capacity to the US power grid and build capabilities in sustainable innovation for broader public benefit.